EUVIMEDEUVIMED entdecken
Crossref

Electrospun Nano-In-Nanofiber Hybrid Platform For Biphasic And Sustained Antidiabetic Drug Release: In Vitro Characterization And Release Kinetics

Satish Digambar Mendake, Dr Santosh Kumar Panda, Dr Amin Fatma, Dr Sameer H Lakade, Dr Bhaskar Nalla, Dr Jitendra Malik, Dr Aniruddha Shamsundar Kulkarni, Mrs Apurva Santosh Pawar

International Journal of Drug Delivery Technology · 13.04.2026 · 16 (8s)

DOI: 10.25258/ijddt.16.8s.81 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 13.04.2026. Verfasst von Satish Digambar Mendake und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

An electrospun nano-in-nanofiber system was developed to achieve a rapid initial and prolonged secondary release of antidiabetic drugs. Metformin and sitagliptin were incorporated via drug-loaded lipid/vesicular nanoparticles embedded in a PVA/gelatin polymer matrix. SEM imaging revealed uniform, bead-free fibers (~500 nm diameter) (Table I). FTIR and DSC confirmed that both drugs were molecularly dispersed without new chemical bond formation[1][2]. The hybrid mat exhibited an initial burst release (≈40% in 2 h) followed by sustained release (≈90% by 24 h, ~100% by 48 h), whereas a plain fiber (no NPs) showed a much faster release (≈80% by 4 h, complete by ~10 h)[3]. Kinetic modeling indicated diffusion-controlled release: the plain fiber fitted Higuchi kinetics well, while the hybrid system required a combination of diffusion and first-order (Korsmeyer–Peppas n≈0.85) to describe the anomalous release[4]. The formulation remained stable (drug content >95% at 6 months) with no alteration in release profile[5]. These results demonstrate that embedding nanoparticles within electrospun fibers can create a biphasic drug delivery system, combining an immediate dose with long-term controlled release, which is desirable for chronic diabetic therapy

Zitieren

APA

Mendake, S. D., Panda, D. S. K., Fatma, D. A., Lakade, D. S. H., Nalla, D. B., Malik, D. J., Kulkarni, D. A. S., & Pawar, M. A. S. (2026). Electrospun Nano-In-Nanofiber Hybrid Platform For Biphasic And Sustained Antidiabetic Drug Release: In Vitro Characterization And Release Kinetics. International Journal of Drug Delivery Technology, 16(8s). https://doi.org/10.25258/ijddt.16.8s.81

Vancouver

Mendake SD, Panda DSK, Fatma DA, Lakade DSH, Nalla DB, Malik DJ, et al. Electrospun Nano-In-Nanofiber Hybrid Platform For Biphasic And Sustained Antidiabetic Drug Release: In Vitro Characterization And Release Kinetics. International Journal of Drug Delivery Technology. 2026;16(8s). doi:10.25258/ijddt.16.8s.81

BibTeX
@article{Mendake2026,
  author = {Mendake, Satish Digambar and Panda, Dr Santosh Kumar and Fatma, Dr Amin and Lakade, Dr Sameer H and Nalla, Dr Bhaskar and Malik, Dr Jitendra and Kulkarni, Dr Aniruddha Shamsundar and Pawar, Mrs Apurva Santosh},
  title = {Electrospun Nano-In-Nanofiber Hybrid Platform For Biphasic And Sustained Antidiabetic Drug Release: In Vitro Characterization And Release Kinetics},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {8s},
  doi = {10.25258/ijddt.16.8s.81}
}
Kostenlos starten →